AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
10.1038/onc.2010.504
Saved in:
Main Authors: | Xu, M.Z., Chan, S.W., Liu, A.M., Wong, K.F., Fan, S.T., Chen, J., Poon, R.T., Zender, L., Lowe, S.W., Hong, W., Luk, J.M. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110722 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
An update on targeting Hippo-YAP signaling in liver cancer
by: Liu, A.M., et al.
Published: (2014) -
Structural basis of YAP recognition by TEAD4 in the Hippo pathway
by: Chen, L., et al.
Published: (2014) -
Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
by: Pulito, C., et al.
Published: (2021) -
THE INTERPLAY BETWEEN RUNX3 AND TEAD-YAP COMPLEX IN GASTRIC CANCER
by: QIAO YITING
Published: (2015) -
SPATIOTEMPORAL CONTROL OF YAP LOCALISATION AND FUNCTION IN VITRO AND IN VIVO
by: TOH JIA YING PEARLYN
Published: (2023)